https://www.selleckchem.com/pr....oducts/mivebresib-ab
BACKGROUND In December 2019, COVID-19 outbreak occurred in Wuhan. Data on the clinical characteristics and outcomes of patients with severe COVID-19 are limited. OBJECTIVE The severity on admission, complications, treatment, and outcomes of COVID-19 patients were evaluated. METHODS Patients with COVID-19 admitted to Tongji Hospital from January 26, 2020 to February 5, 2020 were retrospectively enrolled and followed-up until March 3, 2020. Potential risk factors for severe COVID-19 were analyzed by a multivariable binary logi
Like
Comment
Share
